Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Benhamou

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
Diabetes & Metabolism|December 15, 2024
Screening and care for preclinical stage 1-2 type 1 diabetes in first-degree relatives: French expert position statementRoberto Mallone, Elise Bismuth, Charles Thivolet, et al.
Journal of Diabetes Science and Technology|July 14, 2023
First Generation of a Modular Interoperable Closed-Loop System for Automated Insulin Delivery in Patients With Type 1 Diabetes: Lessons From Trials and Real-Life DataPierre-Yves Benhamou, Alice Adenis, Sandrine Lablanche, et al.
Transplantation Direct|February 13, 2020
Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic ParametersFlorian Terrec, Thomas Jouve, Hamza Naciri-Bennani, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudineConstance Delaugerre, Anne-Geneviève Marcelin, Vincent Thibault, et al.
Clinical Chemistry|July 20, 2007
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stagesThierry Poynard, Philippe Halfon, Laurent Castera, et al.
Journal of Diabetes Science and Technology|August 7, 2014
Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop studyMarie Aude Quemerais, Maeva Doron, Florent Dutrech, et al.
Acta Diabetologica|November 27, 2015
RAGE and CYBA polymorphisms are associated with microalbuminuria and end-stage renal disease onset in a cohort of type 1 diabetes mellitus patients over a 20-year follow-upBenoit Franko, Pierre-Yves Benhamou, Céline Genty, et al.
Advances in Clinical Chemistry|November 14, 2008
Biomarkers of liver fibrosisThierry Poynard, Rachel Morra, Patrick Ingiliz, et al.
Biochimica Et Biophysica Acta|April 15, 2015
Respective effects of oxygen and energy substrate deprivation on beta cell viabilitySandrine Lablanche, Cécile Cottet-Rousselle, Laurent Argaud, et al.
BMC Infectious Diseases|December 17, 2009
Hepatic profile analyses of tipranavir in Phase II and III clinical trialsJaromir Mikl, Mark S Sulkowski, Yves Benhamou, et al.
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Diabetes & Metabolism|December 15, 2024
Screening and care for preclinical stage 1-2 type 1 diabetes in first-degree relatives: French expert position statementRoberto Mallone, Elise Bismuth, Charles Thivolet, et al.
Journal of Diabetes Science and Technology|July 14, 2023
First Generation of a Modular Interoperable Closed-Loop System for Automated Insulin Delivery in Patients With Type 1 Diabetes: Lessons From Trials and Real-Life DataPierre-Yves Benhamou, Alice Adenis, Sandrine Lablanche, et al.
Transplantation Direct|February 13, 2020
Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic ParametersFlorian Terrec, Thomas Jouve, Hamza Naciri-Bennani, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudineConstance Delaugerre, Anne-Geneviève Marcelin, Vincent Thibault, et al.
Clinical Chemistry|July 20, 2007
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stagesThierry Poynard, Philippe Halfon, Laurent Castera, et al.
Journal of Diabetes Science and Technology|August 7, 2014
Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop studyMarie Aude Quemerais, Maeva Doron, Florent Dutrech, et al.
Acta Diabetologica|November 27, 2015
RAGE and CYBA polymorphisms are associated with microalbuminuria and end-stage renal disease onset in a cohort of type 1 diabetes mellitus patients over a 20-year follow-upBenoit Franko, Pierre-Yves Benhamou, Céline Genty, et al.
Advances in Clinical Chemistry|November 14, 2008
Biomarkers of liver fibrosisThierry Poynard, Rachel Morra, Patrick Ingiliz, et al.
Biochimica Et Biophysica Acta|April 15, 2015
Respective effects of oxygen and energy substrate deprivation on beta cell viabilitySandrine Lablanche, Cécile Cottet-Rousselle, Laurent Argaud, et al.
BMC Infectious Diseases|December 17, 2009
Hepatic profile analyses of tipranavir in Phase II and III clinical trialsJaromir Mikl, Mark S Sulkowski, Yves Benhamou, et al.
Pageof 17